Lorlatinib/lorlatinib price

Non-small cell lung cancer One of the most common cancers, lung cancer usually occurs when carcinogens trigger abnormal cell growth in the lungs These cells multiply uncontrollably and eventually form tumors. As a tumor grows, it blocks or narrows the airways, making breathing difficult. Eventually, the tumor cells spread (metastasize) to nearby lymph nodes and other parts of the body, including the liver, bones, adrenal glands, and brain.

Lorlatinib/Lorlatinib is a third-generation targeted drug that has a good effect in the treatment of patients with non-small cell lung cancer with ALK gene mutations. In 201811, lorlatinib was approved for marketing by the USFDA,In 2022 it was approved for sale in China by the State Food and Drug Administration. The cost of domestically imported lorlatinib is relatively high, more than 2 per box, which is not a small amount for most patients and puts great economic pressure. At present, there are many overseas versions of this medicine, and the price is relatively favorable. The retail price of Everest pharmaceutical manufacturers in Bangladesh100mg30tablets5000 is about 1,000 yuan, and the retail price of pharmaceutical manufacturers in Laos and ASEAN is about 100mg30tablets3about 1,780 yuan. The Lao Element Pharmaceutical manufacturer's 100mg 30tablets3 is about 1,780, the retail price of the Lao United Pharmaceutical manufacturer is 3 about 1,780, and the Turkish version of the original drug is about 1 more than 1,000 per box. Patients choose the version based on their own circumstances. If patients decide to contact overseas generic drugs, it is best to choose drugs that are officially marketed overseas and have government approval, so the quality of the drugs is more guaranteed. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.